Production of Basic Fibroblast Growth Factor and Interleukin 6 by Human Smooth Muscle Cells following Infection with Chlamydia pneumoniae

ABSTRACT Chlamydia pneumoniae infection has been associated with asthma and atherosclerosis. Smooth muscle cells represent host cells for chlamydiae during chronic infection. In this study we demonstrated that C. pneumoniae infection of human smooth muscle cells in vitro increased production of interleukin 6 (IL-6) and basic fibroblast growth factor (bFGF) as shown by reverse transcription-PCR, immunoblotting, and enzyme-linked immunosorbent assay. In contrast, levels of platelet-derived growth factor A-chain mRNA were not affected after infection. The stimulation of bFGF and IL-6 production was most effective when viable chlamydiae were used as inoculum. Furthermore, inhibition of bacterial protein synthesis with chloramphenicol prevented up-regulation of IL-6 and bFGF in infected cells. Addition of IL-6 antibody to infected cultures diminished bFGF expression, indicating involvement of produced IL-6. These findings suggest that chlamydial infection of smooth muscle cells elicits a cytokine response that may contribute to structural remodeling of the airway wall in chronic asthma and to fibrous plaque formation in atherosclerosis.

[1]  Airway Remodelling in Asthma , 2006, Archivos de bronconeumologia.

[2]  Xi Yang,et al.  Chlamydia trachomatis (Mouse Pneumonitis Strain) Induces Cardiovascular Pathology following Respiratory Tract Infection , 1999, Infection and Immunity.

[3]  R. Dietz,et al.  Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. , 1999, Circulation.

[4]  B. Coombes,et al.  Chlamydia pneumoniae Infection of Human Endothelial Cells Induces Proliferation of Smooth Muscle Cells via an Endothelial Cell-Derived Soluble Factor(s) , 1999, Infection and Immunity.

[5]  L. Campbell,et al.  Editorial response : The role of Chlamydia pneumoniae in atherosclerosis , 1999 .

[6]  M. Lehmann,et al.  Expression of interferon regulatory factors and indoleamine 2,3-dioxygenase in Chlamydia trachomatis-infected synovial fibroblasts , 1999, Medical Microbiology and Immunology.

[7]  Leinonen,et al.  Asthma, atopy and Chlamydia pneumoniae antibodies in adults , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  J. Ramirez,et al.  Infection of Human Endothelial Cells with Chlamydia pneumoniae Stimulates Transendothelial Migration of Neutrophils and Monocytes , 1999, Infection and Immunity.

[9]  P. Libby,et al.  Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. , 1999, The Journal of clinical investigation.

[10]  D. Hahn,et al.  Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  A. Davies,et al.  Chlamydia pneumoniae and vascular disease , 1998, The British journal of surgery.

[12]  A. Cucina,et al.  Oxidised LDL (OxLDL) induces production of platelet derived growth factor AA (PDGF AA) from aortic smooth muscle cells. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[13]  L. Rabbani,et al.  Inflammatory profile in unstable angina versus stable angina in patients undergoing percutaneous interventions. , 1998, American heart journal.

[14]  B. J. Harrison,et al.  Fibroblast Growth Factors and Their Receptors in Parathyroid Disease , 1998, World Journal of Surgery.

[15]  KatsuhiroYamashita,et al.  Distribution of Chlamydia pneumoniae Infection in the Atherosclerotic Carotid Artery , 1998 .

[16]  J. Ramirez,et al.  Characterization of a Strain of Chlamydia pneumoniae Isolated from a Coronary Atheroma by Analysis of theomp1 Gene and Biological Activity in Human Endothelial Cells , 1998, Infection and Immunity.

[17]  J. Ayres,et al.  Chlamydia pneumoniae and asthma , 1998, Thorax.

[18]  U. Mamat,et al.  Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. , 1998, Journal of the American College of Cardiology.

[19]  D. Agrawal,et al.  Chlamydia pneumoniae and occlusive vascular disease: identification and characterization. , 1998, Journal of pharmacological and toxicological methods.

[20]  D. Hahn,et al.  Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma. , 1998, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  G. Dorn,et al.  Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. , 1997, Journal of Molecular and Cellular Cardiology.

[22]  P. Howarth,et al.  Airway wall remodelling in asthma. , 1997, Thorax.

[23]  D. Martin,et al.  In vitro infection of smooth muscle cells by Chlamydia pneumoniae , 1997, Infection and immunity.

[24]  S. Aho,et al.  Basic FGF regulates interstitial collagenase gene expression in human smooth muscle cells. , 1997, Journal of cellular biochemistry.

[25]  M. Kagnoff,et al.  Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. , 1997, The Journal of clinical investigation.

[26]  J. Ramírez.  Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis , 1996, Annals of Internal Medicine.

[27]  H. Schumacher,et al.  A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples. , 1996, Journal of immunological methods.

[28]  J. Bonner,et al.  Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells. , 1996, The American journal of physiology.

[29]  C. Kroegel,et al.  Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. , 1996, The Journal of allergy and clinical immunology.

[30]  M. Heinemann,et al.  Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line , 1996, Infection and immunity.

[31]  S. Hirst,et al.  Airway smooth muscle cell culture: application to studies of airway wall remodelling and phenotype plasticity in asthma. , 1996, The European respiratory journal.

[32]  J. Bousquet,et al.  Platelet‐derived growth factor in asthma , 1995, Allergy.

[33]  N. Kohno,et al.  Circulating interleukin-6 levels in patients with bronchial asthma. , 1995, American journal of respiratory and critical care medicine.

[34]  E. Zelazny,et al.  IL-1 beta and IL-6 induce hyperplasia and hypertrophy of cultured guinea pig airway smooth muscle cells. , 1995, Journal of applied physiology.

[35]  C. Roberts,et al.  Is asthma a fibrotic disease? , 1995, Chest.

[36]  M. Reidy.  Growth Factors and Arterial Smooth Muscle Cell Proliferation a , 1994, Annals of the New York Academy of Sciences.

[37]  Arndt Rolfs,et al.  PCR: Clinical Diagnostics and Research , 1992 .

[38]  P. Libby,et al.  Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[39]  U. Ikeda,et al.  Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. , 1991, The American journal of physiology.

[40]  M. V. Doyle,et al.  Quantitation of mRNA by the polymerase chain reaction. , 1989, Proceedings of the National Academy of Sciences of the United States of America.